Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $923K | conv 57ClusterFirst in 12mo | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $575.7K | conv 36Cluster | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $136.6K | conv 42Cluster | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $257.3K | conv 33Cluster | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $847.7K | conv 57ClusterFirst in 12mo | SEC | |
Tricida, Inc.Listing unverified | Buy | $57.7K | conv 21First in 12mo | SEC |